Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
Nicola Antonio di Meo(University of Bari Aldo Moro), Giuseppe Lucarelli(University of Bari Aldo Moro), E. Montanari(University of Milan), Davide Loizzo(University of Bari Aldo Moro), Leonardo Vincenti, Cinzia Bizzoca, Francesco Lasorsa(University of Bari Aldo Moro), Michele Battaglia(Mater Dei Hospital), Marco Spilotros(University of Bari Aldo Moro), Pasquale Ditonno(University of Bari Aldo Moro), Felice Crocetto(University of Naples Federico II), Alessandro Stella(University of Bari Aldo Moro), Riccardo Autorino(Rush University Medical Center), Monica Rutigliano(University of Bari Aldo Moro), Savio Domenico Pandolfo(University of Salerno), Matteo Ferro(European Institute of Oncology)
Cited by 190
Related Papers
Evidence of early cortical atrophy in MS
|Neurology|2003|485
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
|Annals of Oncology|2009|205